Antiandrogen monotherapy in patients with localized or locally advanced prostate cancer: final results from the bicalutamide Early Prostate Cancer programme at a median follow-up of 9.7 years

Peter Iversen, David G McLeod, William A See, Thomas Morris, Jon Armstrong, Manfred P Wirth, Casodex Early Prostate Cancer Trialists' Group

    91 Citationer (Scopus)

    Abstract

    To evaluate the efficacy and tolerability of bicalutamide 150 mg once-daily as immediate hormonal therapy in patients with prostate cancer or as adjuvant to radical prostatectomy or radiotherapy.
    OriginalsprogEngelsk
    TidsskriftB J U International (Print)
    Vol/bind105
    Udgave nummer8
    Sider (fra-til)1074-81
    Antal sider8
    ISSN1464-4096
    DOI
    StatusUdgivet - 2010

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Antiandrogen monotherapy in patients with localized or locally advanced prostate cancer: final results from the bicalutamide Early Prostate Cancer programme at a median follow-up of 9.7 years'. Sammen danner de et unikt fingeraftryk.

    Citationsformater